Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05592002 · ClinicalTrials.gov registry record · NA

Safety and Effectiveness of the Genio® bilAteral Stimulation for Treatment of Complete Concentric CollapsE and OSA.

A NA study of Sleep Apnea, Obstructive, sponsored by Nyxoah S.A..

Active
Registry status
NA
Development phase
124
Enrollment target
16
Study locations

NCT05592002 is a NA study of Sleep Apnea, Obstructive that is active but no longer recruiting, run by Nyxoah S.A.. The registered enrollment target is 124 participants, below the 260-participant average among 45 other Sleep Apnea, Obstructive trials with a reported enrollment target (52% lower). The trial reports 16 study locations across 12 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05592002, a NA study of Sleep Apnea, Obstructive, is active but no longer recruiting, sponsored by Nyxoah S.A..

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
124 participants
Enrollment target
16
Study locations

Study Summary

The solution offered by the Genio System to treat OSA patients with CCC using bilateral HGNS has a favorable risk-benefit ratio, as demonstrated by evidence from 2 studies.

Conditions Studied

Interventions

  • DEVICE Genio System

Study Locations (16)

Florida

  • ENT and Allergy Associates of Florida, LLC - Boca Raton
  • University of Miami - Miami
  • PharmaDev Clinical Research Institute, - Miami
  • University of South Florida - Tampa

Pennsylvania

  • Hospital of the University Pennsylvania - Philadelphia
  • Thomas Jefferson University Department of Otolaryngology - Philadelphia

Colorado

  • Colorado ENT & Allergy - Colorado Springs

Indiana

  • Center for ENT and Allergy, PC Ascension Medical Group - Carmel

Iowa

  • University of Iowa Institute for Clinical & Translational Science - Iowa City

Kansas

  • University of Kansas - Kansas City

Massachusetts

  • Massachusetts Eye & Ear - Boston

New York

  • University of Rochester - Rochester

Trial Details

FieldValue
Enrollment Target 124 participants
Start Date 2022-12-28
Est. Completion 2028-09
Phase NA

Sponsor

Nyxoah S.A.

2 total trials

What the Registry Record Tells You About NCT05592002

The ClinicalTrials.gov registry entry for NCT05592002 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 124 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 260-participant average among 45 other Sleep Apnea, Obstructive trials with a reported enrollment target (52% lower). The listed sponsor is Nyxoah S.A., which has 2 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Sleep Apnea, Obstructive appearing as the primary indexed condition, and to 1 intervention - of which Genio System is the first listed.

NCT05592002 reports 16 study locations spanning 12 distinct geographic areas - top geographies include Florida, Pennsylvania, Colorado.

Frequently Asked Questions

What is clinical trial NCT05592002 about?

NCT05592002 is a clinical study titled "Safety and Effectiveness of the Genio® bilAteral Stimulation for Treatment of Complete Concentric CollapsE and OSA.". The solution offered by the Genio System to treat OSA patients with CCC using bilateral HGNS has a favorable risk-benefit ratio, as demonstrated by evidence from 2 studies.

What is the current status of trial NCT05592002?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 124 participants. The study started on 2022-12-28. Estimated completion is 2028-09.

What conditions does trial NCT05592002 study?

This clinical trial studies the following conditions: Sleep Apnea, Obstructive.

What interventions are being tested in trial NCT05592002?

The interventions under investigation include: Genio System (DEVICE).

Who is sponsoring clinical trial NCT05592002?

This trial is sponsored by Nyxoah S.A., which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05592002 being conducted?

This trial has 16 study locations across Colorado, Florida, Indiana, Iowa, Kansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Sleep Apnea, Obstructive

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.